SNY News

Latest SNY News

• Sanofi Discloses October 31, 2026 Share and Voting Rights Figures
  TipRanks European Auto-Generated Newsdesk · Nov 12, 2026
• Sanofi Updates Long-Term Frexalimab Study as Investors Watch Multiple Sclerosis Pipeline
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 12, 2026
• Sanofi Updates Fabry Disease Study: What Investors Should Know
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 12, 2026
• Analysts Have Conflicting Sentiments on These Healthcare Companies: Compass Therapeutics (CMPX), Innate Pharma (IPHA) and Sanofi (OtherSNYNF)
  TipRanks Newsroom · Nov 9, 2026
• Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Sanofi (OtherSNYNF)
  TipRanks Newsroom · Nov 4, 2026
• Analysts Have Conflicting Sentiments on These Healthcare Companies: BioNTech SE (BNTX) and Sanofi (OtherSNYNF)
  TipRanks Newsroom · Nov 4, 2026
• Regeneron and Sanofi Update Long-Term Pediatric Dupixent Study
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 3, 2026
• Analysts Offer Insights on Industrial Goods Companies: Sany Heavy Equipment International Holdings Co (OtherSNYYF) and SEACOR Marine Holdings (SMHI)
  TipRanks Newsroom · Nov 2, 2026
• UBS Sticks to Its Buy Rating for Sany Heavy Equipment International Holdings Co (SNYYF)
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 31, 2026
• Sany Heavy Equipment International Holdings Co (SNYYF) Gets a Buy from CLSA
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 31, 2026
• Sanofi lifts 2026 guidance after strong Q3 driven by Dupixent and new launches
  TipRanks European Auto-Generated Newsdesk · Oct 30, 2026
• Sanofi and Regeneron Advance Dupixent Coformulation in Key Phase 1 Study
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 29, 2026
• Sany Heavy Equipment lifts revenue but faces mixed profit trends in 2026
  TipRanks HongKong Auto-Generated Newsdesk · Oct 29, 2026
• Sanofi Breaks Ground on High-Tech Insulin Plant in Frankfurt to Bolster Global Supply
  TipRanks Auto-Generated Newsdesk · Oct 26, 2026
• Sanofi’s New Oral Alzheimer’s Drug Enters Mid-Stage Trials: What Investors Should Watch
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 23, 2026
• Sanofi Advances Rilzabrutinib Kidney Study, Supporting Long-Term BTK Pipeline Potential
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 23, 2026
• Sanofi Shuts Down Long-Term IBD Drug Study, Nudging Expectations for Future Growth
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 22, 2026
• Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Eli Lilly & Co (LLY) and Sanofi (OtherSNYNF)
  TipRanks Newsroom · Oct 21, 2026
• RBC Capital Reaffirms Their Hold Rating on Sanofi (SNYNF)
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 21, 2026
• Leerink Partners Reaffirms Their Buy Rating on Sanofi (SNYNF)
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 19, 2026